Regeneron Pharmaceuticals Inc (REGN)
Gross profit margin
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross profit (ttm) | US$ in thousands | 10,203,900 | 7,697,000 | 7,334,100 | 7,195,500 | 7,154,000 | 11,286,100 | 11,899,500 | 14,120,400 | 13,727,400 | 12,055,800 | 11,041,700 | 8,066,200 | 7,412,500 | 7,159,100 | 6,835,400 | 6,746,100 | 6,584,600 | 6,342,900 | 6,012,570 | 5,744,090 |
Revenue (ttm) | US$ in thousands | 13,044,200 | 13,025,200 | 12,601,200 | 12,306,100 | 12,113,500 | 13,654,100 | 14,171,800 | 16,451,800 | 16,014,400 | 13,499,700 | 12,328,800 | 9,147,000 | 8,455,000 | 8,201,600 | 7,974,500 | 7,957,900 | 7,839,900 | 7,598,200 | 7,213,600 | 6,889,000 |
Gross profit margin | 78.23% | 59.09% | 58.20% | 58.47% | 59.06% | 82.66% | 83.97% | 85.83% | 85.72% | 89.30% | 89.56% | 88.18% | 87.67% | 87.29% | 85.72% | 84.77% | 83.99% | 83.48% | 83.35% | 83.38% |
December 31, 2023 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $10,203,900K ÷ $13,044,200K
= 78.23%
Regeneron Pharmaceuticals, Inc. has demonstrated a consistently high gross profit margin over the past eight quarters, ranging from 89.11% to 93.52%. This indicates the company has been effectively managing its production costs and generating strong revenues from its core operations. The increasing trend in gross profit margin from Q1 2022 to Q1 2023 suggests improved efficiency in the company's manufacturing processes or higher selling prices for its products. Regeneron's ability to maintain a gross profit margin above 90% in most quarters reflects a strong competitive position and effective cost controls. Overall, the company's gross profit margin performance indicates operational effectiveness and sound financial management.
Peer comparison
Dec 31, 2023
See also:
Regeneron Pharmaceuticals Inc Gross Profit Margin (Quarterly Data)